SKA1 and breast cancer: CircFAT1 facilitates oxaliplatin (OX) resistance in breast cancer by regulating miR-525-5p/SKA1, and the Notch and Wnt pathways can be activated by SKA1, which has been identified by rescue assays, GSEA, and western blotting (89).